Parmar Kush
Entrada Therapeutics, Inc. · Director, 10% Owner
Parmar Kush is listed in filings as Director, 10% Owner at Entrada Therapeutics, Inc.. This profile follows SEC Form 4 activity through Nov 18, 2025, including sale activity. Recent filings connect the profile to Entrada Therapeutics, Inc. (TRDA). The current snapshot covers public activity from Jun 14, 2024 to Nov 18, 2025. Reported amounts are shown as $263.2K to $45.7K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $46k6.4k shares | SellJul 1, 2025 | $7.12 | $6.89 | |
| $44k6.4k shares | SellJun 30, 2025 | $6.81 | $6.89 | |
| $133k19.3k shares | SellJun 27, 2025 | $6.91 | $6.89 | |
| $132k18.6k shares | SellJul 1, 2025 | $7.12 | $6.89 | |
| $127k18.6k shares | SellJun 30, 2025 | $6.81 | $6.89 | |
| $385k55.7k shares | SellJun 27, 2025 | $6.91 | $6.89 | |
| $52k6.9k shares | SellJul 9, 2025 | $7.50 | $6.89 | |
| $151k20.1k shares | SellJul 9, 2025 | $7.50 | $6.89 |